Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.

Aguilar-Guisado, Manuela

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. [electronic resource] - The Lancet. Haematology Dec 2017 - e573-e583 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial

2352-3026

10.1016/S2352-3026(17)30211-9 doi


Adult
Anti-Infective Agents--adverse effects
Bacterial Infections--drug therapy
Diarrhea--etiology
Drug Therapy, Combination
Febrile Neutropenia--complications
Female
Hematologic Neoplasms--complications
Humans
Male
Middle Aged
Mycoses--drug therapy
Nausea--etiology
Risk
Treatment Outcome